即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 1446090-79-4 | 货号 | BCP42783 |
中文名 | Lifirafenib | ||
英文名 | Lifirafenib | ||
中文别名 | |||
英文别名 | BGB-283; BGB 283; BGB283; Beigene-283; | ||
SMILES | C1CC(=O)NC2=NC=CC(=C21)OC3=CC4=C(C=C3)OC5C4C5C6=NC7=C(N6)C=C(C=C7)C(F)(F)F | ||
化学名称 | |||
分子式 | C25H17F3N4O3 | 分子量 | 478.42 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | Lifirafenib is an inhibitor of the serine/threonine protein kinase B-raf (BRAF) and epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Lifirafenib selectively binds to and inhibits the activity of BRAF and certain BRAF mutant forms, and EGFR. This prevents BRAF- and EGFR-mediated signaling and inhibits the proliferation of tumor cells that either contain a mutated BRAF gene or express over-activated EGFR. In addition, BGB-283 inhibits mutant forms of the Ras proteins K-RAS and N-RAS. BRAF and EGFR are mutated or upregulated in many tumor cell types. |
Tags:Lifirafenib 供应商,Lifirafenib 购买,Lifirafenib 生产,Lifirafenib 批量,Lifirafenib 供应,Lifirafenib 订购,Lifirafenib 采购